Ls Investment Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Ls Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $171,238 - $242,288	-1,912 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$68.28 - $123.65 $5,530 - $10,015	-81 Reduced 4.06%	1,912 $214,000
Q4 2019 Jan 31, 2020	BUY	$96.94 - $113.59 $56,709 - $66,450	585 Added 41.55%	1,993 $208,000
Q3 2019 Oct 31, 2019	SELL	$86.25 - $120.16 $862 - $1,201	-10 Reduced 0.71%	1,408 $140,000
Q2 2019 Aug 07, 2019	SELL	$107.38 - $129.34 $17,288 - $20,823	-161 Reduced 10.2%	1,418 $162,000
Q1 2019 Apr 25, 2019	SELL	$105.93 - $142.47 $2,860 - $3,846	-27 Reduced 1.68%	1,579 $198,000
Q4 2018 Feb 01, 2019	BUY	$128.36 - $272.13 $30,549 - $64,766	238 Added 17.4%	1,606 $218,000
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $36,956 - $48,035	-175 Reduced 11.34%	1,368 $376,000
Q2 2018 Jul 20, 2018	SELL	$150.77 - $207.98 $1,809 - $2,495	-12 Reduced 0.77%	1,543 $320,000
Q1 2018 May 08, 2018	SELL	$138.63 - $182.62 $1,247 - $1,643	-9 Reduced 0.58%	1,555 $257,000
Q4 2017 Feb 07, 2018	BUY	$128.36 - $147.04 $14,633 - $16,762	114 Added 7.86%	1,564 $214,000
Q3 2017 Oct 19, 2017	BUY	$120.91 - $137.94 $175,319 - $200,013	1,450	1,450 $197,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.